|
WO2006068647A1
|
|
Internal positive control for probe-based nucleic acid molecule assays and methods of making and using thereof
|
|
WO2005056047A1
|
|
Use of sialic acid, analogues of sialic acid, and antibodies to sialidases as anti-infectious agents and anti-inflammatory agents
|
|
EP1651269A2
|
|
Monoclonal antibodies against ricin toxin and methods of making and using thereof
|
|
CA2517134A1
|
|
Methods for obtaining colonization factors from bacterial strains
|
|
AU2002316755A1
|
|
Fibrinogen bandages and methods
|
|
AU2002252102A1
|
|
Ricin vaccine and methods of making and using thereof
|
|
WO02089810A1
|
|
Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof
|
|
EP1283902A1
|
|
Assay for detecting, measuring and monitoring the activities and concentrations of proteins and methods of use thereof
|
|
WO0180851A1
|
|
Method of treating, preventing or inhibiting central nervous system injuries and diseases
|
|
AU5003500A
|
|
Recombinant vaccine against botulinum neurotoxin
|
|
WO0132207A1
|
|
Methods for conferring active/passive immunotherapy
|
|
AU2729100A
|
|
Methods for conferring active/passive immunotherapy
|
|
EP1047448A1
|
|
Dna vaccines against tick-borne flaviviruses
|
